摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-乙基磺酰哌嗪 | 62937-96-6

中文名称
1-乙基磺酰哌嗪
中文别名
1-乙磺酰基哌嗪
英文名称
1-ethanesulfonylpiperazine
英文别名
1-(ethylsulfonyl)piperazine;1-ethylsulfonylpiperazine
1-乙基磺酰哌嗪化学式
CAS
62937-96-6
化学式
C6H14N2O2S
mdl
MFCD02093528
分子量
178.255
InChiKey
BIYGAOBOLDXNHM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    69-72 °C
  • 沸点:
    110-112°C/0.1mm
  • 密度:
    1.24±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    57.8
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26,S36
  • 危险类别码:
    R22
  • WGK Germany:
    2
  • 海关编码:
    2933599090
  • 储存条件:
    存储条件:2-8°C,避光,密封保存。

SDS

SDS:49e03409c7aa74600c3f92b5e9ea06ef
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Ethylsulfonyl-piperazine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

Section 3. Composition/information on ingredients.
Ingredient name: 1-Ethylsulfonyl-piperazine
CAS number: 62937-96-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H14N2O2S
Molecular weight: 178.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-乙基磺酰哌嗪 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇乙腈 为溶剂, 20.0 ℃ 、344.75 kPa 条件下, 反应 6.0h, 生成 4-[4-(ethylsulfonyl)-1-piperazin-1-yl]phenylamine
    参考文献:
    名称:
    一系列基于咪唑的白色念珠菌抑制剂的合成,生物学评估和结构-活性相关性研究
    摘要:
    合成了一系列新的2-(1H-咪唑-1-基)-1-苯基乙醇衍生物。在体外评估了针对不同真菌种类的抗真菌活性。生物学结果表明,最具活性的化合物具有与氟康唑相当或更高的抗白色念珠菌,非白色念珠菌念珠菌,新隐球菌和皮肤真菌的抗真菌活性。由于它们的外消旋性质,测试了最具活性的化合物5f和6c为纯对映体。对于6c,(R)-对映体比(S)-1具有更高的活性,否则对于5f,(S)-对映体最活跃。为了合理化实验数据,进行了基于配体的计算研究。建模研究的结果表明(小号) - 5F和(- [R )- 6c中完美到基于配体的模型对齐,表现出相同的相对构型。对人肺腺癌上皮细胞(A549)的初步研究表明,6c,5e和5f具有低细胞毒性。
    DOI:
    10.1016/j.ejmech.2014.07.001
  • 作为产物:
    参考文献:
    名称:
    Notes - Preparation of Mono-N-alkyl and -N-Acyl Piperazines by Non hydrolytic Cleavage of 1-Carbethoxypiperazines
    摘要:
    DOI:
    10.1021/jo01357a621
点击查看最新优质反应信息

文献信息

  • Integrase inhibitors
    申请人:Cai R. Zhenhong
    公开号:US20080058315A1
    公开(公告)日:2008-03-06
    Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    三环化合物,其受保护的中间体,以及用于抑制HIV整合酶的方法被披露。
  • PROTEIN KINASE INHIBITORS
    申请人:Sheppard S. George
    公开号:US20070203143A1
    公开(公告)日:2007-08-30
    Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
    抑制蛋白激酶的化合物、含有这些化合物的组合物以及利用这些化合物治疗疾病的方法被披露。
  • INDOL-2-YL-PIPERAZIN-1-YL-METHANONE DERIVATIVES
    申请人:Nettekoven Matthias
    公开号:US20080188484A1
    公开(公告)日:2008-08-07
    The present invention relates to compounds of formula I wherein A and R 1 to R 4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    本发明涉及公式I的化合物,其中A和R1至R4如描述和声明中所定义,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。
  • A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and Pharmaceuticals
    作者:J. Luke Koniarczyk、David Hesk、Alix Overgard、Ian W. Davies、Andrew McNally
    DOI:10.1021/jacs.7b11710
    日期:2018.2.14
    molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label these heterocycles will present opportunities in drug design and facilitate absorption, distribution, metabolism, and excretion (ADME) studies. A broadly applicable protocol is presented wherein pyridines, diazines, and pharmaceuticals are converted into heterocyclic phosphonium
    将氘和氚原子结合到有机分子中的方法对于药物化学很有价值。药物中吡啶和二嗪的流行意味着标记这些杂环的新方法将为药物设计提供机会,并促进吸收、分布、代谢和排泄 (ADME) 研究。提出了一个广泛适用的协议,其中吡啶、二嗪和药物被转化为杂环鏻盐,然后进行同位素标记。同位素以高产率掺入,并且通常具有独特的区域选择性。
  • [EN] AUTOTAXIN INHIBITORS COMPRISING A HETEROAROMATIC RING-BENZYL-AMIDE-CYCLE CORE<br/>[FR] INHIBITEURS DE L'AUTOTAXINE CONTENANT UN NOYAU À CYCLE BENZYLE-AMIDE CYCLIQUE HÉTÉROAROMATIQUE
    申请人:NOVARTIS AG
    公开号:WO2015008230A1
    公开(公告)日:2015-01-22
    The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
    本发明涉及新型化合物,这些化合物是自体磷脂酶抑制剂,涉及它们的制备方法,含有它们的药物组合物和药物,以及它们在由自体磷脂酶介导的疾病和紊乱中的应用。
查看更多